Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression

Ling Zhang, Peng Li, Tiffany Hsu, Hector R. Aguilar, Doug E. Frantz, Jay W Schneider, Robert Bachoo, Jenny Hsieh

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

In the central nervous system (CNS), neural stem cells (NSCs) differentiate into neurons, astrocytes, and oligodendrocytes-these cell lineages are considered unidirectional and irreversible under normal conditions. The introduction of a defined set of transcription factors has been shown to directly convert terminally differentiated cells into pluripotent stem cells, reinforcing the notion that preserving cellular identity is an active process. Indeed, recent studies highlight that tumor suppressor genes (TSGs) such as Ink4a/Arf and p53, control the barrier to efficient reprogramming, leaving open the question whether the same TSGs function to maintain the differentiated state. During malignancy or following brain injury, mature astrocytes have been reported to re-express neuronal genes and re-gain neurogenic potential to a certain degree, yet few studies have addressed the underlying mechanisms due to a limited number of cellular models or tools to probe this process. Here, we use a synthetic small-molecule (isoxazole) to demonstrate that highly malignant EGFRvIII-expressing Ink4a/Arf-/-; Pten-/- astrocytes downregulated their astrocyte character, re-entered the cell cycle, and upregulated neuronal gene expression. As a collateral discovery, isoxazole small-molecules blocked tumor cell proliferation in vitro, a phenotype likely coupled to activation of neuronal gene expression. Similarly, histone deacetylase inhibitors induced neuronal gene expression and morphologic changes associated with the neuronal phenotype, suggesting the involvement of epigenetic-mediated gene activation. Our study assesses the contribution of specific genetic pathways underlying the de-differentiation potential of astrocytes and uncovers a novel pharmacological tool to explore astrocyte plasticity, which may bring insight to reprogramming and anti-tumor strategies.

Original languageEnglish (US)
Pages (from-to)233-242
Number of pages10
JournalDifferentiation
Volume81
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Astrocytes
Gene Expression
Isoxazoles
Tumor Suppressor Genes
Phenotype
Neoplasms
Pluripotent Stem Cells
Histone Deacetylase Inhibitors
Neural Stem Cells
Oligodendroglia
Cell Lineage
Epigenomics
Brain Injuries
Transcriptional Activation
Cell Cycle
Transcription Factors
Down-Regulation
Central Nervous System
Cell Proliferation
Pharmacology

Keywords

  • Astrocyte plasticity
  • Cancer stem cell
  • De-differentiation
  • Epigenetics
  • Glioblastoma

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology
  • Molecular Biology
  • Cancer Research

Cite this

Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression. / Zhang, Ling; Li, Peng; Hsu, Tiffany; Aguilar, Hector R.; Frantz, Doug E.; Schneider, Jay W; Bachoo, Robert; Hsieh, Jenny.

In: Differentiation, Vol. 81, No. 4, 04.2011, p. 233-242.

Research output: Contribution to journalArticle

@article{bbd856fb2c8149319b0853b8dca53e49,
title = "Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression",
abstract = "In the central nervous system (CNS), neural stem cells (NSCs) differentiate into neurons, astrocytes, and oligodendrocytes-these cell lineages are considered unidirectional and irreversible under normal conditions. The introduction of a defined set of transcription factors has been shown to directly convert terminally differentiated cells into pluripotent stem cells, reinforcing the notion that preserving cellular identity is an active process. Indeed, recent studies highlight that tumor suppressor genes (TSGs) such as Ink4a/Arf and p53, control the barrier to efficient reprogramming, leaving open the question whether the same TSGs function to maintain the differentiated state. During malignancy or following brain injury, mature astrocytes have been reported to re-express neuronal genes and re-gain neurogenic potential to a certain degree, yet few studies have addressed the underlying mechanisms due to a limited number of cellular models or tools to probe this process. Here, we use a synthetic small-molecule (isoxazole) to demonstrate that highly malignant EGFRvIII-expressing Ink4a/Arf-/-; Pten-/- astrocytes downregulated their astrocyte character, re-entered the cell cycle, and upregulated neuronal gene expression. As a collateral discovery, isoxazole small-molecules blocked tumor cell proliferation in vitro, a phenotype likely coupled to activation of neuronal gene expression. Similarly, histone deacetylase inhibitors induced neuronal gene expression and morphologic changes associated with the neuronal phenotype, suggesting the involvement of epigenetic-mediated gene activation. Our study assesses the contribution of specific genetic pathways underlying the de-differentiation potential of astrocytes and uncovers a novel pharmacological tool to explore astrocyte plasticity, which may bring insight to reprogramming and anti-tumor strategies.",
keywords = "Astrocyte plasticity, Cancer stem cell, De-differentiation, Epigenetics, Glioblastoma",
author = "Ling Zhang and Peng Li and Tiffany Hsu and Aguilar, {Hector R.} and Frantz, {Doug E.} and Schneider, {Jay W} and Robert Bachoo and Jenny Hsieh",
year = "2011",
month = "4",
doi = "10.1016/j.diff.2011.02.005",
language = "English (US)",
volume = "81",
pages = "233--242",
journal = "Differentiation",
issn = "0301-4681",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression

AU - Zhang, Ling

AU - Li, Peng

AU - Hsu, Tiffany

AU - Aguilar, Hector R.

AU - Frantz, Doug E.

AU - Schneider, Jay W

AU - Bachoo, Robert

AU - Hsieh, Jenny

PY - 2011/4

Y1 - 2011/4

N2 - In the central nervous system (CNS), neural stem cells (NSCs) differentiate into neurons, astrocytes, and oligodendrocytes-these cell lineages are considered unidirectional and irreversible under normal conditions. The introduction of a defined set of transcription factors has been shown to directly convert terminally differentiated cells into pluripotent stem cells, reinforcing the notion that preserving cellular identity is an active process. Indeed, recent studies highlight that tumor suppressor genes (TSGs) such as Ink4a/Arf and p53, control the barrier to efficient reprogramming, leaving open the question whether the same TSGs function to maintain the differentiated state. During malignancy or following brain injury, mature astrocytes have been reported to re-express neuronal genes and re-gain neurogenic potential to a certain degree, yet few studies have addressed the underlying mechanisms due to a limited number of cellular models or tools to probe this process. Here, we use a synthetic small-molecule (isoxazole) to demonstrate that highly malignant EGFRvIII-expressing Ink4a/Arf-/-; Pten-/- astrocytes downregulated their astrocyte character, re-entered the cell cycle, and upregulated neuronal gene expression. As a collateral discovery, isoxazole small-molecules blocked tumor cell proliferation in vitro, a phenotype likely coupled to activation of neuronal gene expression. Similarly, histone deacetylase inhibitors induced neuronal gene expression and morphologic changes associated with the neuronal phenotype, suggesting the involvement of epigenetic-mediated gene activation. Our study assesses the contribution of specific genetic pathways underlying the de-differentiation potential of astrocytes and uncovers a novel pharmacological tool to explore astrocyte plasticity, which may bring insight to reprogramming and anti-tumor strategies.

AB - In the central nervous system (CNS), neural stem cells (NSCs) differentiate into neurons, astrocytes, and oligodendrocytes-these cell lineages are considered unidirectional and irreversible under normal conditions. The introduction of a defined set of transcription factors has been shown to directly convert terminally differentiated cells into pluripotent stem cells, reinforcing the notion that preserving cellular identity is an active process. Indeed, recent studies highlight that tumor suppressor genes (TSGs) such as Ink4a/Arf and p53, control the barrier to efficient reprogramming, leaving open the question whether the same TSGs function to maintain the differentiated state. During malignancy or following brain injury, mature astrocytes have been reported to re-express neuronal genes and re-gain neurogenic potential to a certain degree, yet few studies have addressed the underlying mechanisms due to a limited number of cellular models or tools to probe this process. Here, we use a synthetic small-molecule (isoxazole) to demonstrate that highly malignant EGFRvIII-expressing Ink4a/Arf-/-; Pten-/- astrocytes downregulated their astrocyte character, re-entered the cell cycle, and upregulated neuronal gene expression. As a collateral discovery, isoxazole small-molecules blocked tumor cell proliferation in vitro, a phenotype likely coupled to activation of neuronal gene expression. Similarly, histone deacetylase inhibitors induced neuronal gene expression and morphologic changes associated with the neuronal phenotype, suggesting the involvement of epigenetic-mediated gene activation. Our study assesses the contribution of specific genetic pathways underlying the de-differentiation potential of astrocytes and uncovers a novel pharmacological tool to explore astrocyte plasticity, which may bring insight to reprogramming and anti-tumor strategies.

KW - Astrocyte plasticity

KW - Cancer stem cell

KW - De-differentiation

KW - Epigenetics

KW - Glioblastoma

UR - http://www.scopus.com/inward/record.url?scp=79954616675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954616675&partnerID=8YFLogxK

U2 - 10.1016/j.diff.2011.02.005

DO - 10.1016/j.diff.2011.02.005

M3 - Article

VL - 81

SP - 233

EP - 242

JO - Differentiation

JF - Differentiation

SN - 0301-4681

IS - 4

ER -